Standout Papers

Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, ran... 2022 2026 2023 2024117
  1. Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial (2022)
    Christopher Elnan Kvistad, Halvor Næss et al. The Lancet Neurology

Immediate Impact

30 standout
Sub-graph 1 of 13

Citing Papers

Microbial Fermentation in Food: Impact on Functional Properties and Nutritional Enhancement—A Review of Recent Developments
2025 Standout
The role of glucagon-like peptide-1 receptor (GLP-1R) agonists in enhancing endothelial function: a potential avenue for improving heart failure with preserved ejection fraction (HFpEF)
2025 Standout
2 intermediate papers

Works of Agnethe Eltoft being referenced

Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study
2018
C-reactive protein in atherosclerosis – A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study
2017

Author Peers

Author Last Decade Papers Cites
Agnethe Eltoft 159 71 61 62 13 235
Karin Willeit 104 50 58 133 13 283
Mike Sharma 116 40 24 113 13 243
Long Mo 169 89 44 23 17 272
Chuanqiang Pu 93 29 43 64 11 179
Petr Ševčík 186 85 66 26 15 235
Mai Roose 207 62 98 68 14 294
Friedrich Weymayr 134 27 56 42 11 185
Napasri Chaisinanunkul 212 103 76 25 11 293
Constantin Hecker 149 29 76 22 18 214
Fung Peng Woon 91 29 52 46 17 183

All Works

Loading papers...

Rankless by CCL
2026